Suppr超能文献

癌症和游离 DNA 中的全基因组重复景观。

Genome-wide repeat landscapes in cancer and cell-free DNA.

机构信息

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

Sci Transl Med. 2024 Mar 13;16(738):eadj9283. doi: 10.1126/scitranslmed.adj9283.

Abstract

Genetic changes in repetitive sequences are a hallmark of cancer and other diseases, but characterizing these has been challenging using standard sequencing approaches. We developed a de novo kmer finding approach, called ARTEMIS (Analysis of RepeaT EleMents in dISease), to identify repeat elements from whole-genome sequencing. Using this method, we analyzed 1.2 billion kmers in 2837 tissue and plasma samples from 1975 patients, including those with lung, breast, colorectal, ovarian, liver, gastric, head and neck, bladder, cervical, thyroid, or prostate cancer. We identified tumor-specific changes in these patients in 1280 repeat element types from the LINE, SINE, LTR, transposable element, and human satellite families. These included changes to known repeats and 820 elements that were not previously known to be altered in human cancer. Repeat elements were enriched in regions of driver genes, and their representation was altered by structural changes and epigenetic states. Machine learning analyses of genome-wide repeat landscapes and fragmentation profiles in cfDNA detected patients with early-stage lung or liver cancer in cross-validated and externally validated cohorts. In addition, these repeat landscapes could be used to noninvasively identify the tissue of origin of tumors. These analyses reveal widespread changes in repeat landscapes of human cancers and provide an approach for their detection and characterization that could benefit early detection and disease monitoring of patients with cancer.

摘要

遗传重复序列的变化是癌症和其他疾病的标志,但使用标准测序方法对其进行特征描述一直具有挑战性。我们开发了一种从头发现 kmer 的方法,称为 ARTEMIS(疾病中重复元素的分析),用于从全基因组测序中识别重复元素。使用这种方法,我们分析了来自 1975 名患者的 2837 个组织和血浆样本中的 12 亿个 kmer,其中包括肺癌、乳腺癌、结直肠癌、卵巢癌、肝癌、胃癌、头颈部癌、膀胱癌、宫颈癌、甲状腺癌或前列腺癌患者。我们在 1280 种 LINE、SINE、LTR、转座元件和人类卫星家族的重复元件类型中,在这些患者中发现了肿瘤特异性变化。其中包括已知重复元件的变化和 820 个以前在人类癌症中未发现改变的元件。重复元件在驱动基因区域富集,其表达受结构变化和表观遗传状态的影响。cfDNA 中全基因组重复景观和碎片化特征的机器学习分析在交叉验证和外部验证队列中检测到了早期肺癌或肝癌患者。此外,这些重复景观可用于无创性识别肿瘤的起源组织。这些分析揭示了人类癌症中重复景观的广泛变化,并提供了一种用于检测和特征描述的方法,可能有益于癌症患者的早期检测和疾病监测。

相似文献

1
Genome-wide repeat landscapes in cancer and cell-free DNA.
Sci Transl Med. 2024 Mar 13;16(738):eadj9283. doi: 10.1126/scitranslmed.adj9283.
2
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Selenium for preventing cancer.
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.

引用本文的文献

2
Comprehensive fragmentation of cell-free repetitive DNA for enhanced cancer detection in plasma.
Front Cell Dev Biol. 2025 Jul 9;13:1630231. doi: 10.3389/fcell.2025.1630231. eCollection 2025.
3
Development and clinical applications of liquid biopsy assays in cancer screening.
Transl Cancer Res. 2025 Jun 30;14(6):3846-3859. doi: 10.21037/tcr-2025-272. Epub 2025 Jun 13.
4
SERS-based detection of DNA methylation for cancer diagnosis: Cation-mediated adsorption to silver nanoparticles.
PLoS One. 2025 Jun 13;20(6):e0325539. doi: 10.1371/journal.pone.0325539. eCollection 2025.
5
Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas.
Cell Rep Med. 2025 Jun 17;6(6):102149. doi: 10.1016/j.xcrm.2025.102149. Epub 2025 May 23.
6
Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer.
Sci Adv. 2025 May 23;11(21):eads5002. doi: 10.1126/sciadv.ads5002. Epub 2025 May 21.
7
Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes.
Cancer Discov. 2025 Aug 4;15(8):1593-1608. doi: 10.1158/2159-8290.CD-25-0074.
8
Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid Biopsy.
Mol Diagn Ther. 2025 May;29(3):277-290. doi: 10.1007/s40291-025-00773-x. Epub 2025 Apr 16.
9
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.
Nat Rev Cancer. 2025 May;25(5):341-358. doi: 10.1038/s41568-025-00795-x. Epub 2025 Mar 4.
10
LINE-1 Retrotransposons as Cell-free DNA Biomarkers for Multicancer Early Detection.
Clin Cancer Res. 2025 Apr 1;31(7):1179-1181. doi: 10.1158/1078-0432.CCR-24-4051.

本文引用的文献

1
Transposable elements as tissue-specific enhancers in cancers of endodermal lineage.
Nat Commun. 2023 Sep 1;14(1):5313. doi: 10.1038/s41467-023-41081-4.
2
The complete sequence of a human Y chromosome.
Nature. 2023 Sep;621(7978):344-354. doi: 10.1038/s41586-023-06457-y. Epub 2023 Aug 23.
3
Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer.
Nat Genet. 2023 Aug;55(8):1301-1310. doi: 10.1038/s41588-023-01446-3. Epub 2023 Jul 27.
4
A draft human pangenome reference.
Nature. 2023 May;617(7960):312-324. doi: 10.1038/s41586-023-05896-x. Epub 2023 May 10.
6
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma.
Sci Rep. 2023 Jan 27;13(1):1537. doi: 10.1038/s41598-023-28840-5.
7
Recurrent repeat expansions in human cancer genomes.
Nature. 2023 Jan;613(7942):96-102. doi: 10.1038/s41586-022-05515-1. Epub 2022 Dec 14.
8
Detecting Liver Cancer Using Cell-Free DNA Fragmentomes.
Cancer Discov. 2023 Mar 1;13(3):616-631. doi: 10.1158/2159-8290.CD-22-0659.
9
Epigenetic analysis of cell-free DNA by fragmentomic profiling.
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2209852119. doi: 10.1073/pnas.2209852119. Epub 2022 Oct 26.
10
Repetitive Sequence Transcription in Breast Cancer.
Cells. 2022 Aug 14;11(16):2522. doi: 10.3390/cells11162522.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验